Case Study: Roivant Sciences cuts research time and boosts confidence in in-licensing and company creation with AlphaSense

Roivant Sciences Cuts Research Time and Improves Confidence in In-Licensing, Company Creation, and Operational Decisions

Roivant Sciences, a company that rapidly builds and governs subsidiary biotech and health-tech companies, faced a fragmented, low‑tech research process when evaluating therapies for in‑licensing, acquisitions, and new company creation. To centralize and accelerate diligence across dozens of active projects, Roivant turned to the AlphaSense research platform as an intuitive aggregator for filings, transcripts, analyst reports, presentations, and keyword alerts.

AlphaSense gave Roivant unified document search, real‑time alerts, and consolidated research access across Business Development, Strategic Finance, Corporate Development, and subsidiary teams. The platform enabled Roivant to recreate roughly 85% of past deal specifics from public filings, cut time spent reviewing 10‑Ks and research reports by more than 50%, increase confidence that no public data was missed, and become an integral part of their deal evaluation and competitive tracking workflows.

Roivant Sciences

Sandeep Kulkarni

Vice President of Special Projects / Ombudsman